
Vali oma silt
näidatakse otse viaalilLaboriaruanne
PDF- Testitud
- Thymosin Alpha-1 5mg
- Labor
- Analiza Białek
- Kuupäev
- November 2026
- Tulemus
- 99% purity (5.33 mg measured)
- Endotoksiinid
- 4.56 EU/vial
- Tellimuse nr
- Parool
Sõltumatult testitud, kontrollitav parooliga otse laboris.
Thymosin Alpha-1
Immune System
- Laboris testitud · 99% puhtus
- Saadetakse Saksamaalt
Tellimus
- DHL koos jälgimisega
- Diskreetne pakend
Lühidalt
Thymosin Alpha-1 arvudes
Põhinäitajad meie leksikonist.
Täielik leksikoni artikkel- Class
- Immune-modulating peptidethymus-derived
- Frequency
- ~2x per weekin phases
- Form
- Lyophilised powderreconstituted with BAC water
- Sizes
- 5 to 10 mg2 sizes in the shop
What studies show
The source in the lexiconRandomized controlled study of thymosin alpha-1 in severe sepsis (ETASS) (opens in a new tab)
Wu et al., Critical Care, 2013
Arvustused
Mida kliendid ütlevad
Ainult päris tellimused, milles oli Thymosin Alpha-1.
Kõik arvustusedTeadmised
Kõik teemal Thymosin Alpha-1
Üksikasjalik teave tuleb peagi.
Annustamine
Annustamisteabe laadimine …
Telli kohe kaasa
Mida sul sellega vaja on
Bakteriostaatiline vesi lisatakse ostukorvi automaatselt. Süstlad ja lapid ühe klõpsuga.
Insuliinisüstlad
10 tk · 5.50 €
Alkoholilapid
50 tk · 10 €
Kui palju vett?
Ühikud süstlal sinu viaali suuruse jaoks.
Ava kalkulaator →Is Thymosin Alpha-1 approved?
Yes, but not everywhere. As thymalfasin it is approved in over 35 countries according to a 2009 review, mainly for hepatitis B and C and to strengthen the immune system. There is no approval in the US, ChEMBL lists the compound at phase 3.
How does Thymosin Alpha-1 work?
In cell and mouse experiments it made dendritic cells more active, the cells that show pathogens to the immune system. This ran via the receptor TLR9. At the same time it promoted regulatory T cells, which slow down excessive reactions. ChEMBL lists no confirmed mechanism in humans.
What do the sepsis trials show?
In ETASS with 361 people 26 percent died within 28 days with Thymosin Alpha-1 and 35 percent without, a difference that just missed certainty. The larger TESTS trial with 1,106 people and placebo found 23.4 versus 24.1 percent, so no difference. A possible benefit from age 60 counts only as a hint there.
Are there data on cancer?
In a trial with 488 people with advanced melanoma Thymosin Alpha-1 was added to chemo. The highest study dose was 6.4 mg. More tumours responded and median survival was 9.4 versus 6.6 months, but not statistically certain. There were no extra side effects.
Does it help in severe pancreatitis?
Not with certainty in the TRACE trial with 508 people. Infected dead tissue occurred in 15.7 percent with Thymosin Alpha-1 and 18.1 percent on placebo. The main goal was therefore not reached.
Which side effects are known?
In TESTS 66.4 percent on Thymosin Alpha-1 and 67.6 percent on placebo had an adverse event, serious events were 26.8 versus 29.3 percent. ETASS recorded no serious side effects caused by the drug. With autoimmune disease the regular entry advises restraint.
Seotud
Seotud tooted
Thymalin
Peptiidid · Immuunsüsteem Immuunsüsteem
2 suurust
= alates 16 €/viaal
KPV
Peptiidid · Immuunsüsteem Immuunsüsteem
4 suurust
Laboris testitud
= alates 11.6 €/viaal
VIP
Peptiidid · Immuunsüsteem Immuunsüsteem
2 suurust
= alates 23.2 €/viaal
VIP Nasal
Peptiidid · Immuunsüsteem Immuunsüsteem
1 suurus
Thymosin Alpha-1